Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
ASO Visual Abstract: Timing of Surgical Axillary Staging and Impact on Technical Success of Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection.
Journal: Annals of surgical oncology
Published: August 04, 2026
ASO Visual Abstract: Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma.
Journal: Annals of surgical oncology
Published: July 06, 2026
ASO Author Reflections: Timing of Immediate Lymphatic Reconstruction-Expanding Access without Compromising Technical Success.
Journal: Annals of surgical oncology
Published: June 24, 2026
ASO Visual Abstract: Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis After Neoadjuvant Therapy for Patients with Clinically Node-Negative Hormone Receptor-Positive, HER2-Negative Breast Cancer.
Journal: Annals of surgical oncology
Published: May 26, 2026
Timing of Surgical Axillary Staging and Impact on Technical Success of Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection.
Journal: Annals of surgical oncology
Published: April 23, 2026
ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
Journal: Annals of surgical oncology
Published: March 24, 2026
Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma.
Journal: Annals of surgical oncology
Published: March 10, 2026
Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis following Neoadjuvant Therapy in Patients with Clinically Node-Negative, Hormone Receptor-Positive, HER2-Negative Breast Cancer.
Journal: Annals of surgical oncology
Published: February 18, 2026
International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancer.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 13, 2026
Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
Journal: Annals of surgical oncology
Published: January 20, 2026
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease).
Journal: Therapeutic advances in medical oncology
Published: August 28, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study.
Journal: The Lancet. Oncology
Published: June 06, 2025
Last Updated: 09/26/2026